This is a guide about diabetes mellitus during pregnancy, signs and symptoms, risk factors, effects, both to the pregnancy and child and nursing management
- gestational DM is critical metabolic disorder during pregnancy .
- According to a 2014 analysis by the Centers for Disease Control and Prevention, the prevalence of gestational diabetes is as high as 9.2%
- this presentation is about Gestational DM , introduction , diagnostic criteria , principles of approach and treatment and the sequels of such pregnancy and it`s effect of coming infant .
- this presentation is done by ; Dr. Nawras Mahir Farhan .
- References : most info.s in this presentation , from Dewhurst's Textbook of Obstetrics and Gynaecology, gynecology and obstetrics by ten teachers .
- gestational DM is critical metabolic disorder during pregnancy .
- According to a 2014 analysis by the Centers for Disease Control and Prevention, the prevalence of gestational diabetes is as high as 9.2%
- this presentation is about Gestational DM , introduction , diagnostic criteria , principles of approach and treatment and the sequels of such pregnancy and it`s effect of coming infant .
- this presentation is done by ; Dr. Nawras Mahir Farhan .
- References : most info.s in this presentation , from Dewhurst's Textbook of Obstetrics and Gynaecology, gynecology and obstetrics by ten teachers .
Gestational diabetes Mellitus is defined as:
“Glucose intolerance of any severity with onset or first recognition during pregnancy”
This definition is applicable irrespective of whether the condition resolves after delivery or not.
It does not exclude the possibility that diabetes could have antedated pregnancy.
The Primary Care Physician's guide to management of Pregnancy DiabetesHanifullah Khan
A guide on the screening, diagnosis and management of diabetes in pregnancy aimed at facilitating the handling of this condition in a primary care setting. Includes details on medications and dosages
Please find the power point on Gestational Diabetes Mellitus (GDM) . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Gestational diabetes Mellitus is defined as:
“Glucose intolerance of any severity with onset or first recognition during pregnancy”
This definition is applicable irrespective of whether the condition resolves after delivery or not.
It does not exclude the possibility that diabetes could have antedated pregnancy.
The Primary Care Physician's guide to management of Pregnancy DiabetesHanifullah Khan
A guide on the screening, diagnosis and management of diabetes in pregnancy aimed at facilitating the handling of this condition in a primary care setting. Includes details on medications and dosages
Please find the power point on Gestational Diabetes Mellitus (GDM) . I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Similar to DIABETES MELLITUS DURING PREGNANCY.pptx (20)
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
2. INTRODUCTION
• Diabetes mellitus is a chronic metabolic disorder due to either insulin
deficiency or due to peripheral tissue resistance (decreased sensitivity
to the action of insulin)
• The pathophysiology involved are:
Decreased sensitivity of skeletal muscles and liver to insulin (insulin
resistance) and
Inadequate secretion of insulin
3. Definitions
• Insulinopenia- resulting to a form of diabetes mellitus that results
from an inadequate secretion of insulin
• Hyperinsulinemia- the amount of insulin in your body is higher than
what is considered normal
• MODY- maturity onset diabetes of the young- a rare form of diabetes
which is caused by mutation
• Renal threshold- the lowest blood glucose level that correlated with
the first detectable appearance of urine glucose which is 180 mg/dl
(10.0 mmol/L)
4. TYPES OF DM
• Type–1 (IDDM) is characterized by young age onset (Juvenile) and
absolute insulinopenia. They have genetic predisposition with
presence of autoantibodies.
• Type–2 (NIDDM) is characterized by late age onset, overweight
woman and peripheral tissue (skeletal muscle, liver)insulin resistance
(hyperinsulinemia). Genetic predisposition is also observed.
• Gestational Diabetes Mellitus (GDM)
• Others: Genetic, Drugs, MODY
5. INCIDENCE OF DIABETES MELLITUS DURING
PREGNANCY
• About 1–14% of all pregnancies are complicated by diabetes mellitus
and 90% of them are gestational diabetes mellitus (GDM).
• Nearly 50% of women with GDM will become overt diabetes (type-2)
over a period of 5 to 20 years.
6. GESTATIONAL DIABETES MELLITUS (GDM)
NOMENCLATURE
• GDM is defined as carbohydrate intolerance of variable severity with onset
or first recognition during the present pregnancy.
• The entity usually presents late in the second or during the third trimester.
• The definition is used irrespective of the fact that the condition persists
after pregnancy or not.
• Majority of these women (>50%) with GDM ultimately develop overt
diabetes by next 15 to 20 years.
• It appears that many of these women diagnosed as GDM, are already
suffering from impaired b-cell function but remained undetected. These
cases are basically pre-existing type 2 diabetes.
8. RISK FACTORS
• The potential candidates for GDM are:
• (a) Positive family history of diabetes (parents or sibling). Family history should
include uncles, aunts and grandparents.
• (b) Having a previous birth of an overweight baby of 4 kg or more
• (c) Previous stillbirth with pancreatic islet hyperplasia revealed on autopsy
• (d) Unexplained perinatal loss
• (e) Presence of polyhydramnios or recurrent vaginal candidiasis in present
pregnancy
• (f) Persistent glycosuria
• (g) Age over 30 years
• (h) Obesity
• (i) Ethnic group (East Asian, Pacific island ancestry).
10. SCREENING:
• While some advocate screening routinely to all pregnant mothers, others reserve
it only for the potential candidates.
• Screening strategy for detection of GDM are:
• (a) Low risk—Absence of any risk factors as mentioned above → blood glucose
testing is not routinely required
• (b) Average risk—Some risk factors → perform screening test
• (c) High risk—Blood glucose test as soon as feasible.
• The method employed is by using 50 gm oral glucose challenge test without
regard to time of day or last meal, between 24 weeks and 28 weeks of pregnancy.
• A plasma glucose value of 327 mg% or that of whole blood of 130 mg% at 1 hour
is considered as cut off point for consideration of a 100 gm (WHO– 75 gm)
glucose tolerance test
11. HAZARDS
• (1) Increased perinatal loss is associated with fasting hyperglycemia.
Fetal anomalies are however not increased. This is due to the absence
of metabolic disturbance during organogenesis
• (2) Increased incidence of macrosomia
• (3) Polyhydramnios
• (4) Birth trauma
• (5) Recurrence of GDM in subsequent pregnancies is about 50%.
12. MANAGEMENT
• Diet with 2,000–2,500 Kcal/day for normal weight woman and restriction
to 1,200–1,800 Kcal/day for over weight woman is recommended.
Carbohydrate should be 40–50% of total calories.
• The patient needs more frequent antenatal supervision with periodic
checkup of fasting plasma glucose level which should be less than 90 mg%.
• The control of high blood glucose is done by restriction of diet, exercise
with or without insulin.
• Human insulin (NovoRapid®) should be started if fasting plasma glucose
level exceeds 5.0mmol/L and 2 hours postprandial value is greater than
6.7mmol/L(repetitive) even on diet control.
• Nearly 25% women with GDM need insulin therapy.
• Exercise (aerobic, brisk walking) programs are safe in pregnancy and may
obviate the need of insulin therapy.
13. Obstetric management:
• Women with good glycemic control and who do not require insulin
may wait for spontaneous onset of labor. However, elective delivery
(induction or cesarean section) is considered in patients requiring
insulin or with complications (macrosomia) at around 38 weeks.
14. • Follow-up: Nearly 50% of women with GDM would develop overt
diabetes over a follow-up period of 5–20 years. Women with fasting
hyperglycemia have got worse prognosis to develop type-2 diabetes
and cardiovascular complications.
• Recurrence risk in subsequent pregnancy is more than 50%.
15. EFFECTS OF DIABETES ON PREGNANCY
• Abortion: Recurrent spontaneous abortion may be associated with
uncontrolled diabetes.
• Preterm labor (26%) may be due to infection or polyhydramnios.
• Infection: Urinary tract infection.
• Increased incidence of preeclampsia (25%).
• Polyhydramnios (25–50%) is a common association.
16. References
• Hiralal konar, DC Dutta’s textbook of obstetrics, 8th edition pg 325-334
• Marshal J, Raynor M, Myles textbook for midwives, 16th edition, pg
257-262